Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
State-of-the-art lung cancer radiation therapy
Expert Review of Anticancer Therapy, 10/26/09
Belderbos J et al. – Adaptive radiotherapy monitors the patient over the course of treatment and allows for adaptive treatment–plan modifications to individualize the treatment to the observed patient–specific changes. These techniques thus allow the delivery of higher doses of irradiation that yield a greater probability of complete response, higher tumor control and better survival in irradiated lung cancer patients.
Related Articles
Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab
Journal of Clinical Oncology, 11/12/09
Relevance Score: 82%
Radiation Therapy Technique Successfully Treats Pain In Patients With Advanced Cancer
ScienceDaily, 11/04/09
Relevance Score: 82%
Radiation Treatments Made Safer for Cancer Patients
MedLinePlus, 10/23/09
Relevance Score: 82%
PET imaging response a prognostic factor after thoracic radiation therapy for lung cancer
EurekAlert, 11/09/09
Relevance Score: 81%
New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09
Relevance Score: 81%
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy
Oncogene, 11/25/09
Fhit regulates invasion of lung tumor cells
Oncogene, 11/25/09
Choroidal metastases from lung adenocarcinoma
Clinical and Translational Oncology, 11/25/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
Oncogene, 11/25/09
Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors
Investigational New Drugs, 11/25/09
Adding more content to screening: reactivation of FOXO as a therapeutic strategy
Clinical and Translational Oncology, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


